NCT01152541View on ClinicalTrials.gov

Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
KeratoconusCorneal Ectasia
Interventions
DRUG

Riboflavin/Dextran

Administration of riboflavin/dextran every 2 minutes for the duration of UV exposure

DRUG

Hypotonic Riboflavin

Administration of hypotonic riboflavin every 2 minutes for the duration of UV exposure.

Trial Locations (1)

07666

Cornea and Laser Eye Institute, Teaneck

All Listed Sponsors
lead

Cornea and Laser Eye Institute

OTHER